Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  HYBRIGENICS    ALHYG   FR0004153930

HYBRIGENICS

 (ALHYG)

172
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on HYBRIGENICS
04/08 HYBRIGENICS: Update on the clinical study of inecalcitol in chronic lymphocytic..
03/19 HYBRIGENICS: Hybrigenics' technology platform applied to the study of the aging..
03/14 HYBRIGENICS: Hybrigenics' Technology Platform Successfully Applied to the Study..
01/31 HYBRIGENICS: 2012 revenues and update on the clinical study of inecalcitol in c..
01/29 HYBRIGENICS: launches a new service to screen interactions between small molecu..
2012 HYBRIGENICS: green ligt for two European patents protecting new oral formulatio..
2012 HYBRIGENICS: launches a new website
2012 HYBRIGENICS: Hybrigenics' first half 2012 revenues of EUR 2 million at the same..
2012 HYBRIGENICS: Hybrigenics' General Meeting Highlights
2012 HYBRIGENICS: Bryan, Garnier & Co initiates coverage of Hybrigenics with a targe..
2012 HYBRIGENICS: Bryan Garnier initiates coverage of Hybrigenics with a target pric..
2012 HYBRIGENICS: completed its private placement to institutional investors up to E..
2012 HYBRIGENICS: gets approval and financing for a phase II clinical trial of oral ..
Advertisement
Chart
Duration : Period :
HYBRIGENICS Technical Analysis Chart | ALHYG | FR0004153930 | 4-Traders
Income Statement Evolution
HYBRIGENICS : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.